EGAD00001001913 |
Exome sequencing data for Mesothelioma |
Illumina HiSeq 2500 |
198 |
EGAD00001001914 |
RNA-seq data for mesothelioma cell lines after spliceostatin (SSA) or control (DMSO) treatment. |
Illumina HiSeq 2000 |
12 |
EGAD00001001915 |
RNA-Seq data for Mesothelioma. |
Illumina HiSeq 2000 |
211 |
EGAD00001001916 |
Targeted sequencing using SPET for Mesothelioma. |
Illumina HiSeq 2000 |
207 |
EGAD00001001917 |
PacBio data for mesothelioma cell line NCI-H2595. |
PacBio RS II |
1 |
EGAD00001003919 |
We performed whole genome, whole or targeted exome sequencing for 289 individuals from India. This included 152 clinically diagnosed MODY and 137 control samples. Whole genome libraries were constructed using TruSeqNano DNA Library Preparation Kit (Illumina, CA) and sequenced on Illumina HiSeq2500 (Illumina, CA). The whole exome analysis was performed using Agilent SureSelect (Santa Clara, CA) Human All Exome kit v5 (50 Mb). Exome capture libraries were sequenced on HiSeq 2500 (Illumina, CA). Targeted exome sequencing was performed using custom probes corresponding to 1965 genes implicated in pancreatic cell biology and/or diabetes. |
Illumina HiSeq 2500 |
289 |